Brent R. Logan, Ph.D.
Affiliations: | 2001 | Northwestern University, Evanston, IL |
Area:
StatisticsGoogle:
"Brent Logan"Parents
Sign in to add mentor| Ajit C. Tamhane | grad student | 2001 | Northwestern | |
| (Contributions to multiple endpoints and dose finding.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pasquini MC, Wallace PK, Logan B, et al. (2024) Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300934 |
| Levis MJ, Hamadani M, Logan B, et al. (2024) Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of . Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2302474 |
| Grunebaum E, Arnold DE, Logan B, et al. (2024) Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: a PIDTC study. The Journal of Allergy and Clinical Immunology |
| Versluis J, Saber W, Tsai HK, et al. (2023) Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300866 |
| Leiding JW, Arnold DE, Parikh SH, et al. (2023) Genotype, Oxidase Status, and Preceding Infection or Autoinflammation Do Not Affect Allogeneic HCT Outcomes for CGD. Blood |
| Logan BR, Fu D, Howard A, et al. (2023) Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death. The Journal of Clinical Investigation. 133 |
| Cho C, Devlin S, Maloy M, et al. (2023) Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis. Bone Marrow Transplantation |
| Thakar MS, Logan BR, Puck JM, et al. (2023) Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet (London, England) |
| Sharma A, Logan B, Estrada-Merly N, et al. (2023) Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers. Transplantation and Cellular Therapy |
| Jurdi NE, Martens MJ, Brunstein CG, et al. (2023) Heath-related Quality of Life in Double Umbilical Cord Blood vs. Haploidentical Marrow Transplantation: a QOL Analysis Report of BMT CTN 1101. Transplantation and Cellular Therapy |